title: Cardiovascular risk assessment in the development of new drugs for obesity.
authors.affiliation: University of Colorado School of Medicine, Division of Cardiology and CPC Clinical Research, Aurora, CO 80045, USA. will.hiatt@ucdenver.edu
authors.forename: William R
authors.initials: WR
authors.lastname: Hiatt
authors.forename: Allison B
authors.initials: AB
authors.lastname: Goldfine
authors.forename: Sanjay
authors.initials: S
authors.lastname: Kaul
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002319:Cardiovascular System / Q000187:drug effects*; D002986:Clinical Trials as Topic; D016208:Databases, Factual; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019440:Anti-Obesity Agents